ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Darryl Hudson is Developing Psilocybin-Based Therapeutics"
Episode Synopsis
On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Darryl Hudson, the Co-Founder and CIO of GoodCap Pharmaceuticals.
Darryl Hudson is a PhD in Molecular Biology and Genetics and is active in the Hemp, Cannabis and Psychedelic Drug Development Industries.
GoodCap Pharmaceuticals Inc. (goodcap.com) is a leading Canadian drug development company devoted to harnessing and applying the physical and mental health benefits of mushrooms and mushroom-derived compounds. GoodCap is a leader in formulation, research and development of psilocybin-based therapeutic products and is dedicated to discovering natural therapies for inflammatory disorders and mental health conditions.
Darryl Hudson is a PhD in Molecular Biology and Genetics and is active in the Hemp, Cannabis and Psychedelic Drug Development Industries.
GoodCap Pharmaceuticals Inc. (goodcap.com) is a leading Canadian drug development company devoted to harnessing and applying the physical and mental health benefits of mushrooms and mushroom-derived compounds. GoodCap is a leader in formulation, research and development of psilocybin-based therapeutic products and is dedicated to discovering natural therapies for inflammatory disorders and mental health conditions.
More episodes of the podcast The Psychedelic Invest Podcast
Robert Ansin Builds Bridges To Healing
21/03/2024
In God we trust